US Patent 11352442 Heterodimeric antibodies that bind CD3 and CD38
Patent 11352442 was granted and assigned to Xencor on June, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Gregory Moore0
John Desjarlais0
Matthew J. Bernett0
Rumana Rashid0
Seung Y. Chu0
Umesh Muchhal0
Edits on 2 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113524420
Date of Patent
June 7, 2022
0Patent Application Number
166604150
Date Filed
October 22, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 22 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Patent Citations
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+85 characters)
US Patent 11352442 Heterodimeric antibodies that bind CD3 and CD38
Article
The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11352442
Date of patent
June 7, 2022
Patent application number
16660415
Date Filed
October 22, 2019
Patent citations
Patent primary examiner
CPC Code
Find more entities like US Patent 11352442 Heterodimeric antibodies that bind CD3 and CD38
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
